-
D2 receptor mediated DARPP32/PP1α signaling is responsible for cadmium induced Parkinson’s like behavioral alterations in rats
-
Data driven analysis for exploring phenotypic differences in patients with Parkinson’s disease with or without genetic mutations.
-
DaTscan in clinical evaluation of Multiple System Atrophy
-
DBS Plus: Investigating cell therapy and deep brain stimulation as an approach to alter disease progression and treat motor and non-motor symptoms of Parkinson’s disease
-
Death in patients with Parkinson’s disease – an observational study
-
Decision making under uncertainty in medicated and un-medicated Parkinson’s disesase
-
Decision-making process for opicapone’s bedtime regimen
-
Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns
-
Decreased Fronto-Parietal connection is associated with face pareidolia in Parkinson’s disease.
-
Deep brain recording and surgical time in stereotactic and functional neurosurgery for movement disorders
-
Deep Brain Stimulation (DBS) battery longevity of Medtronic Activa SC is briefer than preceding Soletra models, a within subject analysis
-
Deep Brain Stimulation (DBS) for Parkinson Disease in the Philippines: Outcomes and Practice of the First DBS Center
-
Deep Brain Stimulation and Olfactory Function in Parkinson’s Disease
-
Deep Brain Stimulation for Parkinson Disease before L-dopa treatment: experience in three cases.
-
Deep Brain Stimulation for Parkinson’s disease: Short-term outcomes, referral patterns and health disparities.
-
Deep Brain Stimulation in a case with Parkinsonism and SCA2 mutation: case report highlighting challenges and outcome
-
Deep brain stimulation in Parkinson’s disease: Outcome after more than nine years
-
Deep brain stimulation influences on event-related potentials (P300) in Parkinson’s disease
-
Deep Brain Stimulation of Subthalamic Nucleus Selectively Modulates Striato-Thalamo-Cortical Circuit in Parkinson’s Disease: a Systematic Review and ALE Meta-analysis
-
Deep Learning in Objective Classification of Spontaneous Movement of Patients with Parkinson’s Disease Using Large-Scale Free-Living Sensor Data
-
Defective visual perception in patients with Lewy body disease: assessment of hallucinations with pareidolia test.
-
Deferiprone combined with phlebotomy for aceruloplasminemia
-
Degree, onset and longevity of benefit achieved with Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) as assessed by the UPDRS.
-
Delayed progressive spastic cerebellar ataxia and cerebellar atrophy after Heat Stroke
-
Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.
-
Demographic and Clinical Characteristics and Tetrabenazine (TBZ) Persistence in Patients With Huntington Disease (HD)-Associated Chorea
-
Demographic and Clinical Characters of Parkinson’s Disease in Tertiary Hospital in Kuwait
-
Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes
-
Depression and Cognitive Performance in Patients with Parkinson’s Disease
-
Depression, anxiety and quality of life in Multiple System Atrophy
-
Design and discovery of 1,2,4 triazole derivatives as adenosine A2A receptor antagonist against parkinson’s disease
-
Design and personalisation of new upper-limb dynamic orthoses for dystonia and dyskinesia
-
Design of a randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxin treatment for cervical dystonia (StimTox-CD)
-
Detection of Early Changes in Microbiota Composition in Prodromal Parkinson’s Disease
-
Determinant factors of treatment adherence in Parkinson’s disease
-
Determinants of balance confidence and concern about falling in people with Parkinson’s disease
-
Determinants of health-related quality of life in children and young adults with dystonia
-
Deutetrabenazine is Associated with an Improvement in Involuntary Movements in Patients With Tardive Dyskinesia as Seen by the High Proportion of Responders to Deutetrabenazine Treatment in the AIM-TD Study
-
Deutetrabenazine Treatment Response by Concomitant Dopamine-Receptor Antagonists in the Phase III, Randomized, Double-Blind, Placebo-Controlled AIM-TD Trial in Tardive Dyskinesia
-
Developing a guide to facilitate involving people with Parkinson’s and their carers in service improvement
-
Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale
-
Development and validation of diagnostic criteria for advanced Parkinson disease: the CDEPA questionnaire
-
Development of a Clinical Outcomes Assessment (COA) in Pantothenate-Kinase Associated Neurodegeneration (PKAN): Item Generation and Clinimetric Properties
-
Development of a Clinician-reported Screening Tool to Identify Patients with Parkinson’s disease inadequately controlled on oral medications
-
Development of a New Kinematic Model for Head and Neck Movement Assessment in Cervical Dystonia
-
Development of a Paroxysmal Movement Disorder Diary for Patients with Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
-
Development of a prototype alpha-synuclein vaccine to induce T regulatory cells for the treatment of synucleonopathy
-
Development of nano-formulation containing crocetin for the protective and beneficial effect against 6-hydroxydopamine induced Parkinson’s disease model via altered the genetic backgrounds
-
Development of utility to evaluate a symptomatic diary of motor fluctuations of Parkinson’s disease (PD) using a smartphone application.
-
Dextrometorphan/quinidine in Atypical Parkinsonisms and Huntington Disease
-
Diabetes Mellitus and Parkinson’s Disease
-
Diagnosis of Irritable Bowel Syndrome Increases Risk of Parkinson’s Disease in the Finnish Population
-
Diagnostic utility of regional [18F]AV-1451 tau-PET measurements in PSP
-
Diaphragmatic myoclonus successfully treated with Botulinum toxin A
-
Differences between Hemifacial spasm with or without neurovascular conflict. Therapeutic implications with botulinum toxin type A.
-
Differences in cerebral perfusion between Major depression disorder and depression with Parkinson’s disease : Brain HMPAO SPECT study using SPM analysis
-
Differences in the oscillatory activity of the globus pallidus in dystonia, parkinson´s disease and gilles de la tourette syndrome
-
Differential diagnosis and progress monitoring in Progressive Supranuclear Palsy – a potential role of pulmonary function tests
-
Differential diagnosis of Parkinson’s Disease and Progressive Supranuclear Palsy
-
Differential effects of ventral or dorsal predominant dopaminerjic denervation of striatum on development of dopamine dysregulation syndrome and punding in a rat model of parkinsonism
-
Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)
-
Differential microRNA expression in a cohort of Parkinson’s disease patients
-
Differential peculiarities of cognitive disorders in Parkinson’s disease dementia and Vascular dementia
-
Differentiating Parkinsonism with Spatio-temporal dynamics (real-time MRI) and Acoustics of Speech (spectrogram)
-
Difficulties in executing the MDS recommendations in the brazilian population
-
Diffusion tensor imaging changes in the corpus callosum and cognitive impairment in Parkinson’s disease
-
Diffusion Weighted Magnetic Resonance Imaging in Child Cerebral Palsy with Symptomatic Epilepsy
-
Diffusion-Weighted MRI discriminates Parkinson´s Disease from the Parkinsonian Variant of Multiple System Atrophy: a Meta-analysis
-
Diphasic Dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion: diagnosis and management in clinical practice.
-
Diplopia: An Interesting Complication of Dropped Head Syndrome
-
Direct dopaminergic responsiveness of activity performance
-
Directional distribution of subthalamic nucleus beta activity in patients with Parkinson’s disease
-
Disability-Adjusted Life Years (DALY) in X-linked Dystonia Parkinsonism
-
Disappearance of the clinical and imaging manifestations in Wilson’s disease after controlled therapy with tetrathiomolybdate and zinc
-
Disease modeling for Perry syndrome using patient induced pluripotent stem cells
-
Disease severity is not predictive of the dose required for apomorphine sublingual film (APL-130277) to convert a patient with Parkinson’s disease(PD) from OFF to fully ON: Preliminary Results from a Phase III Study
-
Disease-modification in Translational Models of Parkinson’s disease by the Rho Kinase Inhibitor Fasudil
-
Disease-modifying effect of Zonisamide with the induction of BDNF and TrkB expression
-
Disparities in Access to DBS Surgery Based on Demographics of Patients with PD Admitted for DBS Surgery in the United States from 2003 to 2013
-
Displacement of deep brain stimulation (DBS) lead location after implantation: Preliminary result of a study comparing early Vs late CT findings
-
Disrupted superior collicular activity may reveal cervical dystonia disease pathomechanisms
-
Distinct pattern of striatal dopaminergic depletion in patients with parkin mutation
-
Distinguishing Subclinical Postural Instability in Early-stage Parkinson disease and postural instability of normal elderly using Sensory Organization Test and Limit of Stability
-
Do Acetylcholinesterase Inhibitors (AChEI) delay institutionalisation in Parkinson’s and Lewy Body Disease?
-
Do median-nerve evoked blink reflexes allow early differentiation between PD and PSP in patients with debuting parkinsonism?
-
Do motor symptoms influence on malnutrition in Parkinson`s disease patients?
-
Does cerebellar dysfunction contribute to tremor in Parkinson’s disease?
-
Does gender influence the expression of non-motor symptoms in Parkinson’s disease?: An observational study
-
Does levodopa-carbidopa intestinal gel in Parkinson’s disease patients increase the risk on polyneuropathy?
-
Does Parkinsons KinetiGraph (PKG) recording help in clinical decision making? A local experience
-
Does smoking impact dopamine neuronal loss in de novo Parkinson’s disease?
-
Does the side of onset affect motor and non-motor symptoms in Parkinson’s disease?
-
Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis
-
Domain-specific impact of cerebral white matter hyperintensities on Parkinson’s disease cognitive functioning
-
Dopamine agonist therapy mediates relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease.
-
Dopamine Agonists and Postural Disorders in Parkinson’s disease
-
Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease
-
Dopamine Normalizes Putamen to Insula Activation Shift During Choice Reaction Time Task in PD
-
Dopamine replacement influences on postural motor learning in Parkinson disease
-
Dopamine replacement medication improves acquisition, retention, and transfer of skilled upper extremity movement in people with Parkinson Disease.
-
Dopamine substitution restores effective connectivity between prefrontal and premotor areas in Parkinson’s disease
-
Dopamine transporter imaging predicts motor response to dopaminergic therapy for patients with advanced Parkinson’s disease: Possible role in patient selection for subthalamic deep brain stimulation.
-
Dopamine transporter scan finding in patients with chorea.
-
Double-blind, randomized, placebo-controlled, Phase III study (TOLEDO) to evaluate the efficacy of apomorphine subcutaneous infusion in reducing OFF time in Parkinson’s disease patients with motor fluctuations not well controlled on optimized conventional treatment
-
Down-regulation of miR-9* in the peripheral leukocytes of Huntington’s Disease patients
-
Dr. Paula Coutinho’s Seminal Contributions to the Understanding of Machado-Joseph’s Disease
-
Dream content in Parkinson’s Disease
-
Driving license and car accidents in patients with Parkinson’s disease
-
Drug utilization characteristics in individuals with early Parkinson’s disease interim analysis of the STEADY-PD III study
-
Drug-induced movement disorders: not a typical problem
-
Dural lymphatic vasculature in human superior saggital sinus: the brain drain
-
Dynamic Instability and Stride Width in Parkinsonism
-
Dynamic of symptoms of dopamine dysregulation syndrome after deep brain stimulation in patients with Parkinson`s disease
-
Dynamic prediction of motor diagnosis in Huntington’s disease using a joint modeling approach
-
Dynamic stability during turning in people with Parkinson’s disease
-
Dynamics of brain iron content and cortical pencil lining in healthy aging: An MRI study
-
Dynamics of subthalamic nucleus beta bursts in Parkinson’s disease during ON and OFF dopaminergic state
-
Dysphagia in PSP
-
Dystonia due to bilateral caudate hemorrhage associated with a COL4A1 mutation
-
Dystonia Gravidarum Improved After Joint Position Error Training
-
Dystonia treatment in an international cohort: a longitudinal analysis
-
Dystonia-like phenotype in a DYT1 rat model after peripheral trauma
2017 International Congress
June 4-8, 2017. Vancouver, BC.